driven by the PitchBook Platform
Developer of a drug for the treatment of irritable bowel syndrome with diarrhea. The company is developing ASP7147 which is in phase I Multiple Ascending Dose study.
You’re viewing a free company profile from the PitchBook Platform. To explore Seldar Pharma’s full profile, request a free trial.
© 2018 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.